Accessibility Menu
 
Bio-Techne logo

Bio-Techne

(NASDAQ) TECH

Current Price$57.55
Market Cap$9.00B
Since IPO (1992)+10,275%
5 Year-43%
1 Year+14%
1 Month+13%

Bio-Techne Financials at a Glance

Market Cap

$9.00B

Revenue (TTM)

$1.22B

Net Income (TTM)

$81.10M

EPS (TTM)

$0.51

P/E Ratio

111.90

Dividend

$0.32

Beta (Volatility)

1.16 (Average)

Price

$57.55

Volume

78,158

Open

$55.31

Previous Close

$57.55

Daily Range

$55.28 - $57.68

52-Week Range

$46.01 - $72.16

TECH: Motley Fool Moneyball Superscore

61

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bio-Techne

Industry

Life Sciences Tools and Services

Employees

3,100

CEO

Kim Kelderman

Headquarters

Minneapolis, MN 55413, US

TECH Financials

Key Financial Metrics (TTM)

Gross Margin

65%

Operating Margin

10%

Net Income Margin

7%

Return on Equity

4%

Return on Capital

5%

Return on Assets

3%

Earnings Yield

0.89%

Dividend Yield

0.01%

Payout Ratio

61.50%

Stock Overview

Market Cap

$9.00B

Shares Outstanding

156.45M

Volume

78.16K

Short Interest

0.00%

Avg. Volume

2.42M

Financials (TTM)

Gross Profit

$790.27M

Operating Income

$102.25M

EBITDA

$216.88M

Operating Cash Flow

$287.56M

Capital Expenditure

$31.01M

Free Cash Flow

$256.55M

Cash & ST Invst.

$162.19M

Total Debt

$444.06M

Bio-Techne Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$295.88M

-0.4%

Gross Profit

$191.28M

-1.3%

Gross Margin

64.65%

N/A

Market Cap

$9.00B

N/A

Market Cap/Employee

$2.90M

N/A

Employees

3,100

N/A

Net Income

$38.01M

+8.9%

EBITDA

$77.66M

+7.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$178.02M

+18.2%

Accounts Receivable

$184.61M

-15.3%

Inventory

$205.45M

+9.1%

Long Term Debt

$337.19M

-11.6%

Short Term Debt

$13.71M

+1.5%

Return on Assets

3.21%

N/A

Return on Invested Capital

4.91%

N/A

Free Cash Flow

$76.49M

-1.3%

Operating Cash Flow

$82.41M

-2.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
QGENQiagen N.V.
$41.91+2.49%
BMRNBioMarin Pharmaceutical Inc.
$54.88+0.64%
JAZZJazz Pharmaceuticals plc
$195.31+0.57%
EXELExelixis, Inc.
$44.96+1.56%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$10.37+0.10%
INTCIntel
$65.18+0.04%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.81+0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$50.66+0.03%

Questions About TECH

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.